Literature DB >> 22732193

On the formation and possible biological role of 25-hydroxycholesterol.

Ulf Diczfalusy1.   

Abstract

The oxysterol 25-hydroxycholesterol is a widely used compound displaying an array of pharmacological actions in in vitro systems and cell based experimental systems. In spite of the frequent use of this compound over the last few decades and a large number of studies in vitro and in vivo, its mechanism of formation in vivo is still not well understood. Cholesterol autoxidation does not seem to be an important contributor to in vivo formation of 25-hydroxycholesterol. A number of different cytochrome P450 enzymes such as CYP27A1 and CYP3A4 have been reported to catalyze the conversion of cholesterol to 25-hydroxycholesterol in vitro, but the importance of these reactions in vivo remains unclear. The dioxygenase enzyme cholesterol 25-hydroxylase has been shown to generate 25-hydroxycholesterol, but in cholesterol 25-hydroxylase knockout mice there are still significant levels of 25-hydroxycholesterol in several tissues. This suggests that cholesterol 25-hydroxylase is not the sole producer of 25-hydroxycholesterol. The relative importance of different mechanisms of formation of 25-hydroxycholesterol in vivo have still to be elucidated. The maintenance of cholesterol homeostasis is of great importance to supply tissues with the appropriate amount of cholesterol and prevent accumulation that may affect health. Numerous articles mention 25-hydroxycholesterol as an important regulator of cholesterol metabolism. However, mice with a disruption of the cholesterol 25-hydroxylase gene regulate cholesterol metabolism normally and patients with highly elevated levels of 25-hydroxycholesterol also display normal cholesterol and bile acid levels. These reports challenge the hypothesis that 25-hydroxycholesterol is an important regulator of cholesterol metabolism. Recent reports suggest that 25-hydroxycholesterol and one of its metabolites may have functions in regulation of humoral immunity. Thus, 25-hydroxycholesterol may be more important as a regulator of immunity than as a regulator of cholesterol metabolism.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22732193     DOI: 10.1016/j.biochi.2012.06.016

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  35 in total

1.  Bioorthogonal probes for imaging sterols in cells.

Authors:  Cindy Y Jao; Daniel Nedelcu; Lyle V Lopez; Thilani N Samarakoon; Ruth Welti; Adrian Salic
Journal:  Chembiochem       Date:  2015-02-06       Impact factor: 3.164

2.  Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized Mice.

Authors:  Shin-Ichiro Nitta; Mari Hashimoto; Yasuhiro Kazuki; Shoko Takehara; Hiraku Suzuki; Mitsuo Oshimura; Hidetaka Akita; Kan Chiba; Kaoru Kobayashi
Journal:  AAPS J       Date:  2018-04-09       Impact factor: 4.009

3.  Metabolism of cholesterol and progesterone is differentially regulated in primary trophoblastic subtypes and might be disturbed in recurrent miscarriages.

Authors:  Sigrid Vondra; Victoria Kunihs; Tanja Eberhart; Karin Eigner; Raimund Bauer; Peter Haslinger; Sandra Haider; Karin Windsperger; Günter Klambauer; Birgit Schütz; Mario Mikula; Xiaowei Zhu; Alexander E Urban; Roberta L Hannibal; Julie Baker; Martin Knöfler; Herbert Stangl; Jürgen Pollheimer; Clemens Röhrl
Journal:  J Lipid Res       Date:  2019-09-17       Impact factor: 5.922

4.  25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism.

Authors:  Ying Liu; Zhuo Wei; Xingzhe Ma; Xiaoxiao Yang; Yuanli Chen; Lei Sun; Chuanrui Ma; Qing R Miao; David P Hajjar; Jihong Han; Yajun Duan
Journal:  J Lipid Res       Date:  2018-01-03       Impact factor: 5.922

5.  Cholesterol 25-hydroxylase promotes efferocytosis and resolution of lung inflammation.

Authors:  Jennifer H Madenspacher; Eric D Morrell; Kymberly M Gowdy; Jeffrey G McDonald; Bonne M Thompson; Ginger Muse; Jennifer Martinez; Seddon Thomas; Carmen Mikacenic; Jerry A Nick; Edward Abraham; Stavros Garantziotis; Renee D Stapleton; Julie M Meacham; Mary Jane Thomassen; William J Janssen; Donald N Cook; Mark M Wurfel; Michael B Fessler
Journal:  JCI Insight       Date:  2020-06-04

6.  Steroid hydroxylation by basidiomycete peroxygenases: a combined experimental and computational study.

Authors:  Esteban D Babot; José C Del Río; Marina Cañellas; Ferran Sancho; Fátima Lucas; Víctor Guallar; Lisbeth Kalum; Henrik Lund; Glenn Gröbe; Katrin Scheibner; René Ullrich; Martin Hofrichter; Angel T Martínez; Ana Gutiérrez
Journal:  Appl Environ Microbiol       Date:  2015-04-10       Impact factor: 4.792

7.  Lanosterol Modulates TLR4-Mediated Innate Immune Responses in Macrophages.

Authors:  Elisa Araldi; Marta Fernández-Fuertes; Alberto Canfrán-Duque; Wenwen Tang; Gary W Cline; Julio Madrigal-Matute; Jordan S Pober; Miguel A Lasunción; Dianqing Wu; Carlos Fernández-Hernando; Yajaira Suárez
Journal:  Cell Rep       Date:  2017-06-27       Impact factor: 9.423

8.  IL-1β/TNF-α/IL-6 inflammatory cytokines promote STAT1-dependent induction of CH25H in Zika virus-infected human macrophages.

Authors:  Tshifhiwa Magoro; Aditya Dandekar; Lucas T Jennelle; Rohan Bajaj; Gabriel Lipkowitz; Angelina R Angelucci; Pascal O Bessong; Young S Hahn
Journal:  J Biol Chem       Date:  2019-08-02       Impact factor: 5.157

9.  Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition.

Authors:  Genta Kakiyama; Dalila Marques; Rebecca Martin; Hajime Takei; Daniel Rodriguez-Agudo; Sandra A LaSalle; Taishi Hashiguchi; Xiaoying Liu; Richard Green; Sandra Erickson; Gregorio Gil; Michael Fuchs; Mitsuyoshi Suzuki; Tsuyoshi Murai; Hiroshi Nittono; Phillip B Hylemon; Huiping Zhou; William M Pandak
Journal:  J Lipid Res       Date:  2020-10-02       Impact factor: 5.922

10.  Different oxysterols have opposing actions at N-methyl-D-aspartate receptors.

Authors:  Andrew J Linsenbardt; Amanda Taylor; Christine M Emnett; James J Doherty; Kathiresan Krishnan; Douglas F Covey; Steven M Paul; Charles F Zorumski; Steven Mennerick
Journal:  Neuropharmacology       Date:  2014-05-27       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.